Rein Therapeutics Inc.
Rein Therapeutics Inc. (RNTX) Revenue
Annual & quarterly revenue history · segment & region breakdown
RNTX · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsRein Therapeutics Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Rein Therapeutics Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Rein Therapeutics Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Rein Therapeutics Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
RNTX revenue · 4 questionsRNTX's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Rein Therapeutics Inc. SEC filings · GAAP · Rein Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026